Overview
What is Partnership For Cures?
Partnership For Cures, based in Chicago, Illinois, is a nonprofit organization with a mission to accelerate the availability of treatments for various diseases. They specialize in repurposing research by facilitating clinical trials for already approved therapies, aiming to expedite the development of safe and affordable treatments for a broader patient base. In fiscal year 2023, they initiated or expanded 14 clinical trials in rare diseases, ear, nose, and throat issues, neurology, and oncology, while concluding or closing 7 trials in the same areas. As of July 31, 2023, they have 37 ongoing trials, totaling 44 ongoing trials in their programs. The organization's goal is to deliver treatments more quickly by leveraging the speed, safety, and cost-effectiveness of testing approved therapies for new indications or diseases.
Official website here: www.cureswithinreach.org
Is Partnership For Cures legitimate?
Partnership For Cures is a legitimate nonprofit organization registered as a 501(c)(3) entity. Partnership For Cures submitted a form 990, which is a tax form used by tax-exempt organizations in the U.S., indicating its operational transparency and adherence to regulatory requirements. Donations to this organization are tax deductible.
Here are some key statistics you may want to consider:
Executive Compensation: $183,750
Professional Fundraising Fees: $0
Other Salaries and Wages: $139,786
For more financial information, click here
Official website here: www.cureswithinreach.org
What is the mission statement of Partnership For Cures?
The Partnership For Cures, an organization dedicated to assisting patients, aims to accelerate the availability of treatments for various diseases by funding, vetting, and managing pilot clinical trials. They specifically focus on repurposing already approved drugs, devices, and other products for new indications or diseases without effective treatment. This strategy allows for faster, safer, and more affordable treatments to reach a wider patient base more rapidly. By catalyzing proof-of-concept clinical trials, the organization encourages further funding and research publications, ultimately enabling broader patient use. In fiscal year 2023, they initiated or expanded 14 trials in areas such as rare diseases, neurology, oncology, and ear nose throat, completed or concluded 7 trials, and had 37 trials still in progress as of July 31, 2023.
Official website here: www.cureswithinreach.org
Who is the CEO of Partnership For Cures?
Barbara Goodman is the President Ceo of Partnership For Cures. The CEO's salary of Partnership For Cures is $183,750 and their total compensation is $187,425.
Official website here: www.cureswithinreach.org
What is the revenue of Partnership For Cures?
Partnership For Cures's revenue in 2023 was $2,206,690.
Official website here: www.cureswithinreach.org
Who are the executives of Partnership For Cures and what are their salaries?
The average compensation at Partnership For Cures during 2023 was $107,845. There are 3 employees and 71 volunteers at Partnership For Cures.
Here are 10 key members and their salaries (Partnership For Cures's CEO's salary is $183,750 and their total compensation is $187,425):
- Barbara Goodman (President Ceo)
- Margaret Christie (Chair) [Trustee/Director]
- Lucy Mancini-Newell (Secretary) [Trustee/Director]
- Matthew Rich (Treasurer) [Trustee/Director]
- Kristina Allikmets (Director)
- Steve Braun (Director)
- Nick Manusos (Director)
- Robert Metz (Director)
- David Styler (Director)
- Nancy Sullivan (Director)
Official website here: www.cureswithinreach.org
Where can I find the form 990 for Partnership For Cures?
The Partnership For Cures’s most recent form 990 was submitted in 2023 and can be accessed here
Official website here: www.cureswithinreach.org
Learn more at the official website: www.cureswithinreach.org
Mission Statement of Partnership For Cures
The Partnership For Cures, as an organization, is dedicated to aiding patients by proactively raising funds for initiating and managing pilot human clinical trials. These trials primarily involve testing already approved drugs, devices, and other treatments for potential use in treating various diseases, particularly those that currently lack effective treatment options. The mission of Partnership For Cures is centered around leveraging the speed, safety, and cost-effectiveness of testing approved therapies for new indications or diseases. By doing so, the organization aims to accelerate the delivery of treatments to a broader patient base more swiftly.
In its main area of focus, the Partnership For Cures serves as a catalyst for clinical trials. It achieves this by identifying and facilitating proof-of-concept trials that, when successful, pave the way for further funding and subsequent trials. The ultimate goal is to allow for broader patient use of these treatments and contribute to the publication of scientific findings. In the fiscal year 2023, the organization signed 14 new or expanded clinical trials across various fields, including rare diseases, ear nose throat, neurology, and oncology. Furthermore, seven trials were completed or closed in oncology, rare diseases, neurology, and ear nose throat, while 37 trials remained in progress as of July 31, 2023, totaling 44 ongoing trials.
Impact
This information is meant to be a general summary of Partnership For Cures. Please take the time to review official sources before making any decisions based upon the content provided here.
Thursday, August 15, 2024
Partnership for Cures has a significant impact in the medical research field by helping patients gain access to fast, safe, and affordable treatments. By raising funds to facilitate pilot human clinical trials testing already approved drugs and devices, the organization accelerates the development of new treatments for common and rare diseases. In the fiscal year 2023, the organization signed 14 new or expanded clinical trials in areas such as rare diseases, neurology, and oncology. Additionally, 7 trials were successfully completed in oncology, rare diseases, neurology, and ear nose throat, with a total of 44 ongoing trials as of July 31, 2023. Through their focus on repurposing research and catalyzing clinical trials, Partnership for Cures is making a tangible difference in advancing medical treatments and improving patient outcomes.
Financials
This financial information is from Propublica.
Other financial information:
This information is from the most recently submitted tax form from this organization, which was in 2023.
- Assets and Liabilities:
Organization Details
Founding Year
2005
Phone
(847) 745-1246
Principal Officer
Barbara Goodman
Main Address
134 N LaSalle Street STE 1130, Chicago, IL, 60602
Website
www.cureswithinreach.org
NTEE Category
Code: H12 - Medical research
If you are a representative of Partnership For Cures and wish to learn more about how Give Freely can help you raise funds, please click here: https://givefreely.com/nonprofits/. Our services are offered at no cost to your organization.